Insider filing · ALNY
Yvonne Greenstreet
Chief Executive Officer
profile →
Alnylam Pharmaceuticals, Inc.
ALNY · Healthcare · 57 filings in 24 months
ticker →
Yvonne Greenstreet sold $15.5M of Alnylam Pharmaceuticals (ALNY)
Executed May 30 2025, disclosed Jun 3 2025, 4 days later.
Value, as filed
$15.5M
50,937 sh across 3 lots
Executed
May 30 2025
the trade date, as filed
Disclosed
Jun 3 2025
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
YGYvonne Greenstreet (Chief Executive Officer) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Alnylam Pharmaceuticals, Inc. (ALNY). The largest single filing was $11.5M of ALNY (25,455 sh across 19 lots, as filed), executed Nov 12 2025.
The name
ALNYHealthcare · Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Yvonne Greenstreet in ALNY
ALNYSALE
Alnylam Pharmaceuticals, Inc.
$689K2,130 sh across 4 lots
Exec Mar 4
Filed Mar 6 · 5:30 PM ET ALNYSALE Alnylam Pharmaceuticals, Inc. $2.1M
6,439 sh across 8 lots
Exec Mar 2
Filed Mar 4 · 5:30 PM ET ALNYSALE Alnylam Pharmaceuticals, Inc. $2.2M
6,958 sh × $310.08
Exec Feb 13
Filed Feb 17 · 5:30 PM ET ALNYSALE Alnylam Pharmaceuticals, Inc. $2.8M
7,845 sh across 11 lots
Exec Jan 12
Filed Jan 14 · 5:30 PM ET ALNYSALE Alnylam Pharmaceuticals, Inc. $11.5M
25,455 sh across 19 lots
Exec Nov 12 2025
Filed Nov 14 2025 · 5:30 PM ET ALNYSALE Alnylam Pharmaceuticals, Inc. $4.0M
8,744 sh across 10 lots
Exec Oct 2 2025
Filed Oct 3 2025 · 5:30 PM ET ALNYSALE Alnylam Pharmaceuticals, Inc. $3.0M
6,530 sh across 5 lots
Exec Aug 18 2025
Filed Aug 19 2025 · 5:30 PM ET ALNYSALE Alnylam Pharmaceuticals, Inc. $880K
3,612 sh across 4 lots
Exec Mar 3 2025
Filed Mar 5 2025 · 5:30 PM ET